Drug Discovery Services Market Size, Share & Industry Analysis, By Service Type (Chemistry Services and Biology Services), By Discovery Phase (Target Identification & Validation, Hit Identification, Hit-to-Lead, Lead Optimization, and Others), By Drug Type (Small Molecules and Biologics), By Therapeutic Area (Oncology, Neurological Diseases, Infectious Diseases, Cardiovascular Diseases, and Others), By End User (Pharmaceutical & Biotechnological Companies, Academic & Research Institutes, and Others), and Regional Forecast, 2026-2034

Last Updated: June 23, 2026 | Format: PDF | Report ID: FBI117651

Buy Now

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2021-2034
Base Year	2025
Estimated Year	2026
Forecast Period	2026-2034
Historical Period	2021-2024
Growth Rate	CAGR of 7.0% from 2026 to 2034
Unit	Value (USD Billion)
Segmentation	By Service Type, Discovery Phase, Drug Type, Therapeutic Area, End User, and Region
By Service Type	Chemistry Services Synthetic Chemistry Services Analytical Chemistry Services Others Biology Services In-vitro Profiling Services Toxicology Services Others
By Discovery Phase	Target Identification & Validation Hit Identification Hit-to-Lead Lead Optimization Others
By Drug Type	Small Molecules Biologics
By Therapeutic Area	Oncology Neurological Diseases Infectious Diseases Cardiovascular Diseases Others
By End User	Pharmaceutical & Biotechnological Companies Academic & Research Institutes Others
By Region	North America (By Service Type, By Discovery Phase, By Drug Type, By Therapeutic Area, By End User, and by Country) U.S. (By Drug Type) Canada (By Drug Type) Europe (By Service Type, By Discovery Phase, By Drug Type, By Therapeutic Area, By End User, and by Country/Sub-region) U.K. (By Drug Type) Germany (By Drug Type) France (By Drug Type) Italy (By Drug Type) Spain (By Drug Type) Scandinavia (By Drug Type) Rest of Europe (By Drug Type) Asia Pacific (By Service Type, By Discovery Phase, By Drug Type, By Therapeutic Area, By End User, and by Country/Sub-region) China (By Drug Type) Japan (By Drug Type) India (By Drug Type) Australia (By Drug Type) Southeast Asia (By Drug Type) Rest of Asia Pacific (By Drug Type) Latin America (By Service Type, By Discovery Phase, By Drug Type, By Therapeutic Area, By End User, and by Country/Sub-region) Brazil (By Drug Type) Mexico (By Drug Type) Rest of Latin America (By Drug Type) Middle East & Africa (By Service Type, By Discovery Phase, By Drug Type, By Therapeutic Area, By End User, and by Country/Sub-region) GCC (By Drug Type) South Africa (By Drug Type) Rest of Middle East & Africa (By Drug Type)